http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101094309-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-43 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
filingDate | 2009-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101094309-B1 |
titleOfInvention | Method for producing target-oriented particles by enzyme synthesis |
abstract | The present invention relates to a preparation agent for selectively binding to a specific cell and a method for preparing a particle for drug delivery, wherein the biodegradable, biocompatible PHA synthesized through a PHA synthetase fused with a specific ligand, blocks with the PHA synthetase The copolymer is formed and nanoparticles are made through self-assembly according to the amphipathic properties of them, which is a simple method of preparing nanoparticles to which target ability to selectively bind specific cells of the body such as cancer cells. And nanoparticles for drug delivery.n n n n DDS, PHA, PHB, Integrin, RGD4C, Nano, Cancer Cell, Drug Delivery, Particle, Target |
priorityDate | 2009-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.